1. Home
  2. CADE vs LEGN Comparison

CADE vs LEGN Comparison

Compare CADE & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cadence Bank

CADE

Cadence Bank

HOLD

Current Price

$44.19

Market Cap

7.0B

Sector

Finance

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$23.04

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADE
LEGN
Founded
1876
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
5.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CADE
LEGN
Price
$44.19
$23.04
Analyst Decision
Hold
Strong Buy
Analyst Count
11
13
Target Price
$41.00
$72.42
AVG Volume (30 Days)
2.5M
2.6M
Earning Date
01-21-2026
11-12-2025
Dividend Yield
2.50%
N/A
EPS Growth
N/A
N/A
EPS
2.77
N/A
Revenue
$1,794,761,000.00
$909,045,000.00
Revenue This Year
$16.69
$68.83
Revenue Next Year
$10.30
$51.27
P/E Ratio
$15.88
N/A
Revenue Growth
41.19
74.75
52 Week Low
$25.22
$22.97
52 Week High
$44.24
$45.30

Technical Indicators

Market Signals
Indicator
CADE
LEGN
Relative Strength Index (RSI) 78.20 23.62
Support Level $41.28 $26.43
Resistance Level $42.17 $28.97
Average True Range (ATR) 0.90 1.56
MACD 0.37 -0.37
Stochastic Oscillator 98.65 0.39

Price Performance

Historical Comparison
CADE
LEGN

About CADE Cadence Bank

Cadence Bank is a bank based in the United States. The operating segments are Corporate Banking segment focuses on C&I, business banking, and commercial real estate lending to clients in the geographic footprint, Community Banking segment provides a broad range of banking services through the branch network to serve the needs of community businesses and individual consumers in the geographic footprint, Mortgage segment includes mortgage banking activities of originating mortgage loans, selling mortgage loans in the secondary market and servicing the mortgage loans, Banking Services segment offers individuals, businesses, governmental institutions, and non-profit entities a widerange of solutions to help protect, grow, and transfer wealth, General Corporate and Other segment.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: